Pluxee Announces 2025-2026 Financial Results and 2026-2027 Outlook
10/29/2026
Impact: -65
Healthcare
Pluxee reported recurring EBITDA of €488 million for fiscal 2025–2026, up 3.8% organically, with a 70% cash conversion rate. For 2026–2027, it expects recurring EBITDA of at least €440 million, a decline from the prior year. Management described the year ahead as a transition period, citing economic uncertainty and business adjustments in Brazil following reforms to the local meal voucher program.
AI summary, not financial advice
Share: